Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record for the CM-24 trial is now displayed, including its design, eligibility criteria, locations, outcome measures, and record history.
    Difference
    70%
    Check dated 2026-11-10T18:54:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T18:59:37.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:33:43.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T20:54:03.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the expected content with an access-denied message to indicate the record is not currently reachable.
    Difference
    21%
    Check dated 2026-09-22T21:46:52.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page revision indicator was updated to v3.7.0, replacing the previous v3.6.6, signaling a recent administrative update to the page without altering study details.
    Difference
    0.0%
    Check dated 2026-09-15T21:34:48.000Z thumbnail image

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.